Autres langues Sanofi

Actions

SAN

FR0000120578

Produits pharmaceutiques

Temps réel Euronext Paris 12:02:49 14/09/2026			Varia. 5j.	Varia. 1 janv.
74,87 ^EUR	+2,20%		-1,08%	-9,49%

10:38	Sanofi : Deutsche Bank toujours positif	ZD
10/09	Avis d'analystes du jour : ça bouge sur Orange, Abivax, Ayvens et Rheinemtall

Autres langues

09/09	RBC Launches Sanofi Coverage at Sector Perform Amid Management Turnaround, 'Light' Near-term Catalysts
09/09	EU approves €400 million of German aid for Sanofi insulin factory
09/09	MORNING BRIEFING - Deutschland/Europa
08/09	Börsen treten auf der Stelle - Novartis brechen ein
08/09	AstraZeneca Says Lung-Disease Drug Shows Benefits Across Patient Groups
08/09	EU genehmigt Millionen für Sanofi - Insulinfabrik in Hessen
07/09	Can A Dominant Firm’s Communications Strategy Amount To Exclusionary Conduct?
04/09	Europa todavía esconde "gangas" : cinco acciones con más de un 30% de potencial
02/09	Owkin signs AI drug discovery deal with Boehringer for cancer, immunology
01/09	Regeneron Seen Weighing Expanded Sanofi Deal, RBC Says
01/09	Global pharma companies that have publicly announced Trump drug pricing agreements
01/09	Novartis Shares Climb After Pill Hits Goals in Multiple Sclerosis Trials
01/09	Novartis-Aktie steigt nach MS-Studienerfolg - Rückschlag bei Zelltherapie
01/09	Novartis MS pill beats older drug in trials, boosts pipeline hopes
01/09	Novartis-Arznei erreicht gegen Multiple Sklerose in Klinik primäre Ziele
01/09	Novartis Drug Meets Key Goal in Late-Stage Multiple Sclerosis Trials
31/08	Arrowhead Pharmaceuticals' sHTG Therapy Could Get FDA Approval by Q2 2027, RBC Says
31/08	Novavax's Partnership Strategy Continues to Deliver with XFG-adapted Nuvaxovid Approvals in the U.S., EU and Japan for 2026-2027 Vaccination Season
28/08	Novavax, Inc., Sanofi S.A., And Takeda Pharmaceutical Company Limited Receive Approvals For XFG-Adapted Nuvaxovid Formulation In The U.S., European Union And Japan For 2026-2027 Vaccination Season
28/08	FDA genehmigt saisonale Covid-19-Impfstoffe von Biontech und anderen
28/08	FDA Approves Seasonal Covid-19 Vaccines From Moderna, Pfizer, BioNTech, Novavax -- Update
28/08	Novavax's Nuvaxovid Approved in US, EU, Japan for 2026-2027 Season
27/08	US FDA approves updated COVID vaccines for 2026-27 season
27/08	European Equities Traded in the US as American Depositary Receipts Track Lower in Thursday Trading
27/08	AstraZeneca-Amgen asthma drug succeeds in late-stage oesophagus disease trial